Prospective, Randomized, Placebo Controlled Trial of the Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients

Trial Profile

Prospective, Randomized, Placebo Controlled Trial of the Efficacy and Safety of Inhaled Nitric Oxide (NO) in Cystic Fibrosis (CF) Patients

Recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Mar 2017

At a glance

  • Drugs Nitric oxide (Primary)
  • Indications Cystic fibrosis; Cystic fibrosis-associated respiratory tract infections
  • Focus Therapeutic Use
  • Sponsors Novoteris
  • Most Recent Events

    • 23 Feb 2017 Status changed from not yet recruiting to recruiting.
    • 21 Sep 2016 Planned initiation date changed from 1 Sep 2015 to 1 Nov 2016.
    • 21 Sep 2016 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top